Abstract:Objective To investigate the expression and clinical significance of visceral adipose tissue-derived serine protease inhibitor (Vaspin) in nonalcoholic fatty liver disease (NAFLD). Methods The clinical and pathological data of 78 patients with NAFLD undergoing ultrasound-guided fine-needle aspiration in liver tissues from October 2016 to October 2019 in our hospital were retrospectively analyzed. Hematoxylin and eosin staining and Gomori methenamine silver staining were used to observe the degree of inflammation and fibrosis of liver tissues. The immunohistochemical staining was used to detect the expression of Vaspin and transforming growth factor-β (TGF-β). The correlations of the expression of Vaspin and TGF-β with the degree of inflammation, fibrosis, serum total cholesterol (TCHO), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gammaglutamyltransferase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL), direct bilirubin (DBIL), fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) were analyzed. Logistic regression model was applied to analyze the influencing factors for NAFLD. Results The Vaspin expression negatively correlated with TG (rs = -0.279,P < 0.05), but positively correlated with LDL-C and FPG (rs = 0.352 and 0.312, both P < 0.05); TGF-β expression negatively correlated with ALP (rs =-0.225, P < 0.05). Logistic regression analysis showed that Vaspin expression [O^R = 2.987 (95% CI: 1.065, 8.379)], ALT [O^R = 1.062 (95% CI: 1.014, 1.112)], TBIL [O^R = 1.502 (95% CI: 1.147, 1.967)], and FPG [ O^R = 13.111 (95% CI: 1.430, 120.195)] were risk factors for NAFLD. Conclusion The high expression of Vaspin in liver tissue indicates the severe condition of NAFLD.